1. Impact of Diabetes on Pathologic Response to Multimodality Therapy for Esophageal Cancer
   Stephanie G. Worrell et al, 2024, The Annals of Thoracic Surgery CrossRef
2. Obesity and colorectal cancer: molecular features of adipose tissue
   Javier Martinez-Useros et al, 2016, Journal of Translational Medicine CrossRef
3. Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
   Justin C Brown et al, 2020, JNCI Cancer Spectrum CrossRef
4. Serum from morbidly obese patients affects melanoma cell behavior in vitro
   Débora Mocellin et al, 2022, Brazilian Journal of Pharmaceutical Sciences CrossRef
5. Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro
   Melanie Arul et al, 2017, In Vitro Cellular & Developmental Biology - Animal CrossRef
6. Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer
   Justin C. Brown et al, 2018, PLOS ONE CrossRef
7. IGF-1 and IGFBP-3 in cancer patients
   Zofia Stasik, 2019, Diagnostyka Laboratoryjna CrossRef
8. The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia
   Soudeh Ghafouri-Fard et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
9. Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
   Sahitya K. Denduluri et al, 2015, Genes & Diseases CrossRef
10. Cell-based assays for IGF-I bioactivity measurement: overview, limitations and current trends
    Charlotte Ramadhin et al, 2014, Growth Factors CrossRef
11. Dose–response effects of exercise on insulin among colon cancer survivors
    Justin C Brown et al, 2018, Endocrine-Related Cancer CrossRef